LivaNova PLC Operating Lease, Right-of-Use Asset, Amortization Expense
LivaNova PLC (LIVN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $5.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- LivaNova PLC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $2.78M, a 25.29% decline year-over-year.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $2.73M, a 32.33% decline year-over-year.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $2.64M, a 38.01% increase year-over-year.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $2.97M, a 16.88% increase year-over-year.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $13.37M, a 51.43% increase from fiscal 2024.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $8.83M, a 17.08% decline from fiscal 2023.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for fiscal 2023 was $10.65M, a 4.13% increase from fiscal 2022.
- LivaNova PLC operating lease, right-of-use asset, amortization expense for fiscal 2022 was $10.22M, a 39.62% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.51M 10-Q · filed 2026-08-05 | $8.15M derived: sum of 3 quarters · filed 2026-08-05 | $11.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.73M 10-Q · filed 2026-05-06 | $5.37M derived: sum of 2 quarters · filed 2026-05-06 | $8.34M derived: sum of 3 quarters · filed 2026-05-06 | $12.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.61M derived: sum of 2 quarters · filed 2026-02-25 | $9.33M derived: sum of 3 quarters · filed 2026-08-05 | $13.37M 10-K · filed 2026-02-25 |
| 2025-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.70M derived: sum of 2 quarters · filed 2026-08-05 | $10.73M 10-Q · filed 2025-11-05 | $12.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.76M 10-Q · filed 2026-08-05 | $9.67M derived: sum of 3 quarters · filed 2026-08-05 | $12.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $4.04M 10-Q · filed 2026-05-06 | $5.95M derived: sum of 2 quarters · filed 2026-05-06 | $8.49M derived: sum of 3 quarters · filed 2026-05-06 | $10.32M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.45M derived: sum of 2 quarters · filed 2026-02-25 | $6.28M derived: sum of 3 quarters · filed 2026-02-25 | $8.83M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.37M derived: sum of 2 quarters · filed 2025-11-05 | $6.92M 10-Q · filed 2025-11-05 | $10.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $4.38M 10-Q · filed 2025-08-06 | $7.75M derived: sum of 3 quarters · filed 2026-02-25 | $9.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-07 | $5.92M derived: sum of 2 quarters · filed 2026-02-25 | $8.08M derived: sum of 3 quarters · filed 2026-02-25 | $10.55M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.54M derived: sum of 2 quarters · filed 2026-02-25 | $8.01M derived: sum of 3 quarters · filed 2026-02-25 | $10.65M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $4.63M derived: sum of 2 quarters · filed 2024-10-31 | $7.27M 10-Q · filed 2024-10-31 | $10.39M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.11M 10-Q · filed 2024-08-01 | $8.23M derived: sum of 3 quarters · filed 2025-02-25 | $10.39M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.64M 10-Q · filed 2024-05-03 | $5.77M derived: sum of 2 quarters · filed 2025-02-25 | $7.93M derived: sum of 3 quarters · filed 2025-02-25 | $10.21M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.29M derived: sum of 2 quarters · filed 2025-02-25 | $7.57M derived: sum of 3 quarters · filed 2025-02-25 | $10.22M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $4.45M derived: sum of 2 quarters · filed 2023-11-01 | $7.10M 10-Q · filed 2023-11-01 | $11.90M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $4.94M 10-Q · filed 2023-07-26 | $9.74M derived: sum of 3 quarters · filed 2024-02-29 | $12.93M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.65M 10-Q · filed 2023-05-03 | $7.46M derived: sum of 2 quarters · filed 2024-02-29 | $10.64M derived: sum of 3 quarters · filed 2024-02-29 | $14.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.99M derived: sum of 2 quarters · filed 2024-02-29 | $11.55M derived: sum of 3 quarters · filed 2024-02-29 | $16.93M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $6.74M derived: sum of 2 quarters · filed 2022-11-02 | $12.13M 10-Q · filed 2022-11-02 | $16.30M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $8.95M 10-Q · filed 2022-08-03 | $13.11M derived: sum of 3 quarters · filed 2023-02-27 | $16.63M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $5.39M 10-Q · filed 2022-05-04 | $9.55M derived: sum of 2 quarters · filed 2023-02-27 | $13.07M derived: sum of 3 quarters · filed 2023-02-27 | $16.23M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.68M derived: sum of 2 quarters · filed 2023-02-27 | $10.84M derived: sum of 3 quarters · filed 2023-02-27 | $13.98M 10-K · filed 2023-02-27 |
| 2020-09-30 | $3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $6.68M derived: sum of 2 quarters · filed 2021-11-03 | $9.81M 10-Q · filed 2021-11-03 | $13.15M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $6.30M 10-Q · filed 2021-07-28 | $9.63M derived: sum of 3 quarters · filed 2022-03-01 | $12.26M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $3.14M 10-Q · filed 2021-04-28 | $6.47M derived: sum of 2 quarters · filed 2022-03-01 | $9.10M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.96M derived: sum of 2 quarters · filed 2022-03-01 | $12.30M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $8.96M 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $6.33M 10-Q · filed 2020-07-29 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |